HS 30 · USD 2B+ potential; world-class biotech
COMMODITY FACTSHEETS
All Frontier Global Nexus · Commission-Only · allfrontierglobal.com
Commodity Overview
Trade Intelligence
Applicable FTAs and duty rates: Use AJG FTA Savings Estimator at allfrontierglobal.com/tools/fta-savings-estimator.php
Rules of Origin requirements for preferential duty claim under applicable FTA
Key trade bodies and certification authorities for this commodity
Major buyers/sellers and typical contract structures (annual, spot, forward)
Port of loading/discharge logistics and transit times
Mandate Opportunities
Sell mandate: India exporter seeking buyer in priority markets listed above
Buy mandate: International buyer seeking India source / India buyer seeking import
Bilateral: Regular, recurring supply arrangement between established counterparts
Multilateral: Commodity in multi-country supply chain (e.g., India API → UAE → Africa)
AJG Intelligence
This factsheet is part of AJG's 80,000+ data point commodity database. All mandates for Biosimilars & Biologics — Emerging Export Segment (HS 30) are facilitated commission-only by All Frontier Global Nexus.
allfrontierglobal.com/commodities/Pharma-Biosimilars.php
| Parameter | Details |
|---|---|
| Commodity | Biosimilars & Biologics — Emerging Export Segment |
| HS Code(s) | 30 |
| Annual Trade Value | USD 2B+ potential; world-class biotech |
| Key Indian Cities / Ports | hyderabad,pune,bengaluru |
| Required Certifications | USFDA BLA, EMA biosimilar guideline, WHO-PQ |
| Priority Markets | USA, EU, Australia, Japan, Brazil, South Africa |
| Mandate Type | Sell, buy, or bilateral — commission-only |